BioSpace News Archive

Drug Development

Biopharma Invested Just $6.5B in Vaccine Development in Last Decade: Report

The clinical development pipeline for vaccines is broad but shallow with a large proportion of programs dedicated to COVID-19, according to a new report by industry group Biotechnology Innovation Organization.

January 29, 2024
·
2 min read
·
Tristan Manalac
Policy

J&J, Merck CEOs Agree to Testify Before Senate Panel and Dodge Subpoena

The CEOs of J&J and Merck have finally committed to testifying before the Senate health committee regarding the high prices of drugs in the U.S. The hearing is set for Feb. 8.

January 29, 2024
·
2 min read
·
Tristan Manalac
Deals

Alto Neuroscience, Fractyl Health Join IPO Surge with Detailed Offering Plans

On the heels of ArriVent and CG Oncology’s upsized IPOs last week, Alto Neuroscience and Fractyl Health on Monday announced their respective plans to go public.

January 29, 2024
·
2 min read
·
Tyler Patchen
Drug Development

Merck’s Keytruda Gets Back-to-Back Phase III Wins in Kidney, Bladder Cancer

The blockbuster immunotherapy secured separate late-stage victories as an adjuvant-setting treatment in renal cell carcinoma and muscle-invasive urothelial carcinoma.

January 29, 2024
·
2 min read
·
Tristan Manalac
Drug Development

BMS’s Opdivo Fails for Second Time in Late-Stage Kidney Cancer Trial

Bristol Myers Squibb’s PD-1 inhibitor was unable to outperform the placebo arm in improving disease-free survival in renal cell carcinoma patients at high risk of relapse after surgery.

January 29, 2024
·
2 min read
·
Tristan Manalac
Deals

The combination of Novozymes and Chr. Hansen is now successfully completed, creating Novonesis – a leading global biosolutions partner

On December 12, 2022, Novozymes and Chr. Hansen entered into an agreement to create a leading global biosolutions partner through a statutory merger of the two companies.

January 29, 2024
·
8 min read
Business

Kraton Completes $35M Investment in Biorefinery Towers at Panama City Facility

Kraton Corporation has completed a $35 million investment to upgrade its crude tall oil biorefinery towers in its Panama City, Florida manufacturing facility.

January 29, 2024
·
2 min read
Biotech Beach

AntiCancer Inc. Has Received a New Patent That Revolutionizes Individualized Mouse Models of Human Cancer Patients by Increasing the Patient-tumor Establishment Rate in Mice to Close to 100%

AntiCancer Inc. announced it has just received US Patent 11,871,731 that describes a method to increase the rate of establishment of patient tumors in mice to close to 100%.

January 29, 2024
·
1 min read
Biotech Bay

Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock - Jan 29, 2024

Vera Therapeutics, Inc. announced its plans to commence a public offering, subject to market and other conditions, to issue and sell $200.0 million of shares of its Class A common stock.

January 29, 2024
·
3 min read
Biotech Beach

BIOLASE REPORTS UNAUDITED REVENUE GROWTH FOR FULL YEAR 2023 AND PROVIDES OUTLOOK FOR FULL YEAR 2024

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced preliminary unaudited revenue results for 2023 based on currently available information and expects to report year-over-year growth as it continues to generate interest among dental practitioners for its industry leading lasers.

January 29, 2024
·
7 min read